VANECK PHARMACEUTICAL ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.57 EUR | -0.22% |
|
-0.59% | +16.93% |
Investment objective
VanEck Vectors Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 905.4 USD | -0.40% | +2.43% | +55.32% | 11.58% | ||
| 146.2 USD | +0.25% | -1.74% | -6.75% | 6.43% | ||
| 123.8 USD | -4.64% | -5.29% | +13.56% | 6.38% | ||
| 171.5 USD | +1.50% | +0.66% | +10.68% | 5.59% | ||
| 225.3 USD | -1.17% | -4.81% | +9.70% | 4.73% | ||
| 584 USD | -1.54% | -3.16% | +26.15% | 4.72% | ||
More news
In partnership with
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 85.57 | -0.22% |
| 27/06/24 | 85.76 | -0.96% |
| 26/06/24 | 86.59 | -0.41% |
| 25/06/24 | 86.95 | +0.27% |
| 24/06/24 | 86.72 | +0.74% |
Other stock markets
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 08:47 pm
More quotesETF Ratings
 |
Description
| US92189F6925 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | Actions |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Fund Structure | |
| Replication Model | |
| Date of creation |
19/12/2011
|
| Geographical Focus |
AuM evolution ( 30/05/2024 )
| AuM (EUR) | 524 M€ |
|---|---|
| AuM 1M | 479 M€ |
| AuM 3 months | 475 M€ |
| AuM 6 months | 365 M€ |
| AuM 12 months | 358 M€ |
- Stock Market
- ETF
- VEFV ETF
